E1	Condition:T1 Name:T18
E2	Criteria-Count:T2 Min-Value:E18 Criteria:E3 Criteria2:E5
E3	Condition:T3 Name:T27
E4	Modifier:T4 Modifies:T27
E5	Procedure:T5 Name:T28
E6	Study:T6 Study-Of:E19
E7	Assertion:T7 Asserted:E20
E8	Condition:T8 Name:T21
E10	Condition:T10 Name:T22
E12	Study:T12 
E14	Assertion:T14 Asserted:E25
E17	Study:T17 
E18	Eq-Comparison:T25 Value:T26
E19	Procedure:T29 
E20	Study:T30 Temporality:E21 Study-Of:E22 Study-Of2:E23
E21	Eq-Comparison:T31 Temporal-Period:T19
E22	Drug:T32 Name:T33
E23	Drug:T34 Name:T35
E25	Condition:T15 Name:T37
T1	Condition 58 62	LOPD
T2	Criteria-Count 96 109	the following
T3	Condition 121 131	deficiency
T4	Modifier 135 145	GAA enzyme
T5	Procedure 156 170	GAA genotyping
T6	Study 234 239	study
T7	Assertion 312 324	eligible for
T8	Condition 414 422	pregnant
T10	Condition 426 439	breastfeeding
T12	Study 443 452	screening
T14	Assertion 495 503	planning
T17	Study 535 540	study
T18	Condition-Name 58 62	LOPD
T19	Eq-Temporal-Period 342 349	ongoing
T20	Life-Stage-And-Gender 403 409	female
T21	Condition-Name 414 422	pregnant
T22	Condition-Name 426 439	breastfeeding
T23	Life-Stage-And-Gender 476 480	male
T24	Life-Stage-And-Gender 484 490	female
T25	Eq-Comparison 89 92	one
T26	Eq-Value 89 92	one
T27	Condition-Name 121 131	deficiency
T28	Procedure-Name 156 170	GAA genotyping
T29	Procedure 248 258	procedures
T30	Study 350 364	clinical trial
T31	Eq-Comparison 342 349	ongoing
T32	Drug 371 377	ATB200
T33	Drug-Name 371 377	ATB200
T34	Drug 378 384	AT2221
T35	Drug-Name 378 384	AT2221
T15	Condition 507 523	conceive a child
T37	Condition-Name 507 523	conceive a child
A1	Assertion-Type-Value E7 hypothetical
A3	Assertion-Type-Value E14 intention
A6	Eq-Temporal-Period-Value T19 present
A7	Life-Stage-And-Gender-Type T20 female
A8	Life-Stage-And-Gender-Type T23 male
A9	Life-Stage-And-Gender-Type T24 female
R1	If-Then Arg1:T20 Arg2:E8
R2	Or Arg1:E8 Arg2:E10
R3	During Arg1:E10 Arg2:E12
R4	Or Arg1:T23 Arg2:T24
R5	During Arg1:E25 Arg2:E17
R6	Or Arg1:E22 Arg2:E23
